Bigdata analytics identifies metabolic inhibitors and promoters for productivity improvement and optimization of monoclonal antibody (mAb) production process
Caitlin Morris(University of Massachusetts Lowell), Seongkyu Yoon(University of Massachusetts Lowell), Michael Borys(Bristol-Myers Squibb (United States)), Bethanne M. Warrack(Bristol-Myers Squibb (United States)), Michael D. Reily(Pfizer (United States)), Ashli Polanco(University of Massachusetts Lowell), Seo‐Young Park(Korea Research Institute of Bioscience and Biotechnology), Zheng Jian Li(Beihang University), Jia Zhao(Shenyang Normal University), Andrew Yongky(University of Minnesota), Jianlin Xu(Bristol-Myers Squibb (United States)), Kevin S. McFarland(Johns Hopkins University), Zhuangrong Huang(University of Massachusetts Lowell)
Cited by 18
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Pretreatment of lignocellulosic biomass for enhanced biogas production
|Progress in Energy and Combustion Science|2014|1.3k
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project
|Toxicology and Applied Pharmacology|2003|386
A comparison of several organosolv pretreatments for improving the enzymatic hydrolysis of wheat straw: Substrate digestibility, fermentability and structural features
|Applied Energy|2015|145
Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective
|Environment International|2018|111